Ian Taylor - Mar 1, 2022 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Chief Scientific Officer
Signature
/s/ Matthew Batters as attorney-in-fact for Ian Taylor
Stock symbol
ARVN
Transactions as of
Mar 1, 2022
Transactions value $
$56,000
Form type
4
Date filed
3/3/2022, 08:00 PM
Previous filing
Mar 4, 2022
Next filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Options Exercise $56K +3.5K +4.45% $16.00 82.1K Mar 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARVN Stock Option (right to buy) Options Exercise $0 -596 -100% $0.00* 0 Mar 1, 2022 Common Stock 596 $16.00 Direct F1
transaction ARVN Stock Option (right to buy) Options Exercise $0 -925 -6.25% $0.00 13.9K Mar 1, 2022 Common Stock 925 $16.00 Direct F2
transaction ARVN Stock Option (right to buy) Options Exercise $0 -1.98K -22.13% $0.00 6.96K Mar 1, 2022 Common Stock 1.98K $16.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022.
F2 This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022.
F3 This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022.